Prognostic gene expression profiling in melanoma: necessary steps to incorporate into clinical practice

Prognostic gene expression profiling (GEP) tests for cutaneous melanoma (CM) are not recommended in current guidelines outside of a clinical trial. However, their use is becoming more prevalent and some practitioners are using GEP tests to guide patient management. Thus, there is an urgent need to b...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Melanoma Manag
Main Authors: Grossman, Douglas, Kim, Caroline C, Hartman, Rebecca I, Berry, Elizabeth, Nelson, Kelly C, Okwundu, Nwanneka, Curiel-Lewandrowski, Clara, Leachman, Sancy A, Swetter, Susan M
Formato: Artigo
Idioma:Inglês
Publicado em: Future Medicine Ltd 2019
Assuntos:
Perspective
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6920745/
https://ncbi.nlm.nih.gov/pubmed/31871621
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/mmt-2019-0016
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados